Organogenesis Holdings (ORGO) Asset Writedowns and Impairment (2018 - 2024)
Organogenesis Holdings (ORGO) posted quarterly Asset Writedowns and Impairment of $18.8 million for Q2 2024, up 2303.74% quarter-over-quarter from -$855000.0 in Q4 2022.
Organogenesis Holdings (ORGO) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends
Organogenesis Holdings' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $18.8 million for Q2 2024.
- In Q2 2024, Asset Writedowns and Impairment changed N/A year-over-year to $18.8 million; the TTM figure through Dec 2024 stood at $18.8 million (up 15544.26% YoY), while the FY2024 annual figure was $18.8 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q2 2024 stood at $18.8 million, up from -$855000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $18.8 million in Q2 2024, with the low at -$1.4 million in Q4 2020.
- The 4-year median for Asset Writedowns and Impairment is $632000.0 (2021), against an average of $1.8 million.
- Peak annual rise in Asset Writedowns and Impairment reached 2937.5% in 2020, while the deepest fall reached 613.43% in 2020.
- Organogenesis Holdings' Asset Writedowns and Impairment stood at -$1.4 million in 2020, then jumped by 145.93% to $632000.0 in 2021, then tumbled by 235.28% to -$855000.0 in 2022, then jumped by 2303.74% to $18.8 million in 2024.
- Business Quant data shows ORGO's Asset Writedowns and Impairment at $18.8 million in Q2 2024, -$855000.0 in Q4 2022, and $733000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 18.84 Mn |
| Jun 30, 2024 | 18.84 Mn |
| Dec 31, 2022 | -855,000.00 |
| Dec 31, 2022 | -855,000.00 |
| Sep 30, 2022 | 733,000.00 |
| Sep 30, 2022 | 733,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 632,000.00 |
| Dec 31, 2021 | 632,000.00 |
| Sep 30, 2021 | 868,000.00 |
| Sep 30, 2021 | 868,000.00 |
| Jun 30, 2021 | 575,000.00 |
| Jun 30, 2021 | 575,000.00 |
| Mar 31, 2021 | 921,000.00 |
| Mar 31, 2021 | 921,000.00 |
| Dec 31, 2020 | -1.38 Mn |
| Dec 31, 2020 | -1.38 Mn |